Skip to main content
Rating Scales GDS-SV©
LICENSABLE PSYCHIATRIC RATING SCALE

(GDS-SV)© – Geriatric Depression Scale Short Version

GDS-SV©

Clinical Overview

The Geriatric Depression Scale Short Version (GDS-SV)© represents a streamlined adaptation of the original 30-item Geriatric Depression Scale, specifically developed by Sheikh and Yesavage to provide efficient depression screening in older adult populations. This 15-item self-administered instrument was designed to address the unique challenges of depression assessment in geriatric patients, utilizing a simple yes/no response format that accommodates cognitive and physical limitations commonly encountered in elderly populations. The GDS-SV eliminates somatic symptoms that may be confounded by medical conditions, focusing instead on cognitive and emotional aspects of depression.

Developed through rigorous psychometric analysis of the original GDS, the short version maintains excellent diagnostic accuracy while significantly reducing administration burden. The scale’s straightforward format and age-appropriate content make it particularly suitable for use in primary care settings, nursing homes, community health programs, and clinical research involving older adults. Its proven ability to detect depression across diverse geriatric populations, including those with mild cognitive impairment, establishes it as an essential tool for comprehensive geriatric assessment and mental health screening.

Key Validation Points

  • Extensive Geriatric Validation – Developed by Sheikh and Yesavage (1986) from the original 30-item scale. Meta-analysis of 42 studies places pooled sensitivity at 81.3% and specificity at 78.4% for the 15-item form (Wancata et al., 2006), giving it better diagnostic accuracy than the long form
  • Cross-Cultural Reliability – Available in more than 30 languages through the Stanford Aging Clinical Research Center, with established measurement invariance supporting international geriatric research and clinical applications
  • Cognitive Impairment Sensitivity – Proven effectiveness in detecting depression among older adults with mild to moderate cognitive impairment, maintaining accuracy in early dementia populations
  • Medical Setting Validation – Extensively validated in primary care, nursing home, hospital, and community settings with established cut-off scores for various geriatric populations
  • Longitudinal Stability – Strong test-retest reliability and demonstrated sensitivity to treatment-related changes in depression severity over time
  • Research Integration – Among the most widely used geriatric depression screening instruments in the peer-reviewed literature (view current citation count on PubMed)

Primary Use Cases

  • Primary Care Depression Screening – Routine screening tool for depression in older adults during annual wellness visits, chronic disease management, and preventive care assessments
  • Nursing Home Assessment – Standard depression screening instrument for long-term care facilities, assisted living communities, and geriatric residential care settings
  • Clinical Trial Applications – Screening and outcome measure in geriatric depression treatment studies, including antidepressant trials and psychotherapy research in older adult populations
  • Geriatric Specialty Care – Assessment tool for geriatricians, geriatric psychiatrists, and mental health professionals specializing in older adult care
  • Population Health Research – Epidemiological studies, health services research, and community-based depression prevalence studies in aging populations

Licensing Information

Professional Licensing Available

This validated psychiatric rating scale is available for licensing to qualified organizations, research institutions, and clinical practices. Our licensing agreements provide you with the legal rights to use this assessment tool in your clinical trials, research studies, or patient care programs.

Licensing includes: Scale administration rights, scoring guidelines, technical documentation, and ongoing support for proper implementation.

Request Licensing Information

Interested in licensing this scale for your research or clinical practice? Complete the form below and our team will contact you with detailed licensing information, pricing, and implementation support.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*